Does the issue of stored blood get old: is all blood equal?
P. Przybyłowski,B. Hudzik
DOI: https://doi.org/10.20452/pamw.4072
2017-08-03
Polish Archives of Internal Medicine
Abstract:473 CI, 3.43–28.30; P <0.001), major vascular compli‐ cation (OR, 12.40; 95% CI, 7.37–20.83; P <0.001), and severe anemia (OR, 3.47; 95% CI, 1.95–6.18; P <0.001). All of these predictors were associated with an increased risk of transfusion of at least 4 RBC units.4 Unquestionably, there are other fac‐ tors that predict transfusion, such as lower body mass index, renal dysfunction, and antiplate‐ let and anticoagulant regimens. Several mecha‐ nisms have been proposed to explain the associ‐ ation of blood transfusion with worse outcomes. These include the impairment of oxygen delivery due to an increased oxygen affinity and decrease in deformability of stored RBCs, prothrombot‐ ic effects through an increased release of proco‐ agulants, and transfusion ‐related modulation of the immune system through alterations in cyto‐ kine levels.8 In addition, whether pretreatment of anemia (eg, iron substitution, erythropoietin) prior to TAVI improves the outcome remains to be determined, because anemia may just act as an indicator of frailty in these patients. Still, one could anticipate that the mitigation of anemia could result in a reduction in transfusion rates.9 In this issue of the Polish Archives of Internal Medicine, Czerwińska ‐Jelonkiewicz et al10 focused on different aspects of blood transfusion in pa‐ tients who underwent TAVI. The authors investi‐ gated the association between RBC storage time and the short‐ and long ‐term outcomes in this population of patients. In this retrospective, ob‐ servational study, 101 patients (56.7%) required blood transfusion during or after TAVI. Given that the mean number of transfused RBC units was 2 and the mean hemoglobin concentration prior to transfusion was 9.6 g/dl, patients were managed with a liberal rather than restrictive ap‐ proach to RBC transfusion. One could only spec‐ ulate whether the treatment of preexisting ane‐ mia prior to TAVI could have resulted in a fewer Transcatheter aortic valve implantation (TAVI) has become a viable therapeutic modality for in‐ operable or high‐surgical‐risk patients with se‐ vere aortic stenosis, who are not deemed suit‐ able for surgical aortic valve replacement. Bleed‐ ing and vascular access site complications range from 26% to 77% and 9.5% to 51.6%, respective‐ ly, and have been well documented to be associat‐ ed with worse outcomes.1 Aortic stenosis by itself could lead to hemolysis, which in turn may con‐ tribute to anemia. Bleeding events often require packed red blood cell (RBC) transfusion. Howev‐ er, the clinical decision regarding the necessity of RBC transfusion is challenging. Studies have shown that baseline anemia is the strongest pre‐ dictor of the need for RBC transfusion following both TAVI and aortic valve replacement.2,3 Not‐ withstanding, everyday clinical practice indicates that RBC transfusions are being administered in the absence of overt major bleeding or hemody‐ namic instability. More importantly, we must be aware that not every major bleeding results in a significant hemoglobin drop and thus may not require RBC transfusion. Increased mortality, stroke, and acute kid‐ ney injury rates have been reported in patients who received RBC transfusions following TAVI.4 The adverse effects of bleeding, anemia, and blood transfusion on short‐ and long ‐term outcomes are not just specific for TAVI. In addition, blood transfusion has been linked to worse prognosis following acute coronary syndromes,5 percuta‐ neous coronary intervention,6 and cardiac sur‐ gery.7 Tchetche et al4 identified independent pre‐ dictors of RBC transfusion following TAVI. These included female sex (odds ratio [OR], 2.11; 95% CI, 1.32–3.37; P = 0.002), previous cerebrovascular accident (OR, 1.95; 95% CI, 1.13–3.38; P = 0.016), peripheral vascular disease (OR, 1.94; 95% CI, 1.18–3.20; P = 0.01), major stroke (OR, 9.85; 95% EDITORIAL